C-Reactive Protein Alters Antioxidant Defenses and Promotes Apoptosis in Endothelial Progenitor Cells
- 1 November 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (11) , 2476-2482
Abstract
Objective—C-reactive protein (CRP) has been suggested to participate in the development of atherosclerosis, in part, by promoting endothelial dysfunction and impairing endothelial progenitor cell (EPC) survival and differentiation. In the present study, we evaluated the effects of CRP on antioxidative enzymes, reactive oxygen species production, telomerase activity, and apoptosis in human circulating EPCs.Methods and Results—EPCs, isolated from peripheral venous blood, were cultured in the absence or presence of native pentameric azide and lipopolysaccharide (LPS)-free CRP (0, 5, 15, and 20 μg/mL), N-acetylcysteine (NAC), hydrogen peroxide (H2O2) or monoclonal anti-CRP antibodies. Fluorescence-activated cell sorter (FACS) analysis was used for the measurement of intracellular H2O2and superoxide (O2−) by loading cells with 2′,7′-dichlorodihydrofluorescein diacetate (H2DCF-DA). Apoptosis was evaluated with Annexin V immunostaining and cytosolic cytochrome c expression. Western blot analysis was used for the determination of manganese superoxide dismutase (MnSOD) and glutathione peroxidase expression, and polymerase chain reaction enzyme-linked immunosorbent assay was used to assess telomerase activity. Incubation of EPCs with CRP caused a concentration dependent increase in reactive oxygen species (ROS) production and apoptosis, with an effect quantitatively similar to H2O2. This effect was attenuated during coincubation with NAC or anti-CRP antibodies. Furthermore, CRP altered EPC antioxidative enzyme levels, demonstrating a reduced expression of glutathione peroxidase and a significant increase in MnSOD expression. Transfection of EPCs with MnSOD-RNAi resulted in a reduction in CRP-induced ROS production, apoptosis, and telomerase inactivation.Conclusions—CRP, at concentrations known to predict cardiovascular events, may serve to impair EPC antioxidant defenses, and promote EPC sensitivity toward oxidant-mediated apoptosis and telomerase inactivation. These data further support a direct role of CRP in the development and/or progression of atherothrombosis.Keywords
This publication has 37 references indexed in Scilit:
- Limiting Myocardial Damage during Acute Myocardial Infarction by Inhibiting C-Reactive ProteinNew England Journal of Medicine, 2006
- Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein ItselfCirculation Research, 2005
- FcγRIIB Mediates C-Reactive Protein Inhibition of Endothelial NO SynthaseCirculation Research, 2005
- C-Reactive Protein Decreases Tissue Plasminogen Activator Activity in Human Aortic Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Proapoptotic, Antimigratory, Antiproliferative, and Antiangiogenic Effects of Commercial C-Reactive Protein on Various Human Endothelial Cell Types In VitroCirculation Research, 2005
- C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?Hypertension, 2004
- C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and FunctionCirculation, 2004
- Antioxidants Inhibit Nuclear Export of Telomerase Reverse Transcriptase and Delay Replicative Senescence of Endothelial CellsCirculation Research, 2004
- C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial CellsCirculation, 2003
- Endothelial Progenitor CellsCirculation, 2003